A team of scientists from the University of Sheffield and University of Copenhagen have discovered an enzyme which helps breast cancer spread, and in the process, have found a possible way to prevent the spread of breast cancer-secondary or metastatic cancer-in patients. Bones are the most common routes breast cancer takes as it spreads, involved in about 85 percent of secondary breast cancer cases.
In light of promising results conducted by an independent data monitoring committee, Pfizer’s newest treatment IBRANCE (Palbociclib) ended clinical trials early this week as phase 3 of the trials ended demonstrating improvement in progression-free survival in women who had undergone treatment for metastatic breast cancer.